Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597506 | SCV000703773 | uncertain significance | not provided | 2016-12-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002232231 | SCV001674196 | likely benign | Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000597506 | SCV001788454 | likely benign | not provided | 2020-10-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456301 | SCV002735801 | likely benign | Cardiovascular phenotype | 2021-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000597506 | SCV003799986 | likely benign | not provided | 2022-09-16 | criteria provided, single submitter | clinical testing |